Traumatic Brain Injury (TBI) diagnosis and treatment are unmet needs in medical field.
No diagnostic tools for assessing the extent and severity of a TBI exist.
Threapy development is at the core of Medicrotex R&D plan.
In the future, TBI and stroke patients will have a valid diagnostic tool and treatment.
Medicortex Finland is dedicated to improving the diagnosis, treatment and prevention of acute neurodegenerative conditions and is currently focused on developing a novel multiplex treatment for traumatic brain injury.